IP Library Granted Patent US 7,094,791
Granted Patent B2
US 7,094,791 · App. 10/631,887 · Granted Aug 22, 2006

Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,094,791
App. No.
10/631,887
Granted
Aug 22, 2006
Kind
B2
Abstract

Chemical agents of the general formula (I) and (II), such as derivatives of 3-hydroxy-pyrrole containing hydroxamic acid, and including salts thereof, that modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents.

Claims (107)

1. A compound having the structure of Formula (I) or Formula (II)

wherein:

R 1 is selected from H, substituted and unsubstituted alkyl, substituted and unsubstituted aryl, substituted and unsubstituted arylalkyl, substituted and unsubstituted heteroarylalkyl, and substituted and unsubstituted cycloalkyl;

R 2 is selected from H, substituted and unsubstituted alkyl, substituted and unsubstituted alkenyl, substituted and unsubstituted alkynyl, substituted and unsubstituted heteroalkyl, substituted and unsubstituted aryl, substituted and unsubstituted arylalkyl, substituted and unsubstituted heteroarylalkyl, and substituted and unsubstituted cycloalkyl;

R 3 is selected from a substituted and unsubstituted alkyl or a substituted and unsubstituted heteroalkyl;

R 4 is selected from H, substituted and unsubstituted alkyl, substituted and unsubstituted heteroalkyl, substituted and unsubstituted aryl, substituted and unsubstituted arylalkyl, substituted and unsubstituted heteroarylalkyl, and substituted and unsubstituted cycloalkyl;

R 3 and R 4 can be connected together to form a pyridine or piperidine ring;

R 5 is selected from H, substituted and unsubstituted alkyl, substituted and unsubstituted heteroalkyl, substituted and unsubstituted aryl, substituted and unsubstituted arylalkyl, substituted and unsubstituted pyridine, substituted and unsubstituted cycloalkyl, and substituted and unsubstituted piperidine;

X and Y are independently selected from substituted and unsubstituted alkyl, substituted and unsubstituted alkenyl, substituted and unsubstituted alkynyl, substituted and unsubstituted heteroalkyl, substituted and unsubstituted haloalkyl, substituted and unsubstituted aryl, substituted and unsubstituted arylalkyl, substituted and unsubstituted pyridine, substituted and unsubstituted cycloalkyl, substituted and unsubstituted piperidine, CO 2 , CO and SO 2 ,

wherein a, b and c are each independently 0 or 1, and

including pharmaceutically acceptable salts thereof.

2. The compound of claim 1 , wherein R 1 is —H, lower substituted and unsubstituted alkyl, substituted and unsubstituted benzyl, substituted and unsubstituted alkoxybenzyl, substituted and unsubstituted dialkylamino alkyl.

3. The compound of claim 2 , wherein R 1 is methyl or substituted and unsubstituted benzyl.

4. The compound of claim 1 , wherein R 2 is —H, lower substituted and unsubstituted alkyl, substituted and unsubstituted arylalkyl, or.

5. The compound of claim 4 , wherein R 2 is substituted or unsubstituted arylalkyl with 0–4 substituents selected from alkoxy, F, Cl, Br, CN, 2,4-dichloro, 3,4-dichloro, 2,6-dichloro, and 3,4-difluoro.

6. The compound of claim 1 , wherein R 3 is selected from substituted and unsubstituted alkyl or substituted and unsubstituted heteroalkyl.

7. The compound of claim 1 , wherein R 4 is —H or substituted or unsubstituted lower alkyl.

8. The compound of claim 1 , wherein R 4 and R 3 form a pyridine ring.

9. The compound of claim 1 , wherein R 4 and R 3 form a piperidine ring.

10. The compound of claim 1 , wherein X is alkyl, heterolakyl, or aryl.

11. The compound of claim 1 , wherein X is pyridine.

12. The compound of claim 1 , wherein X is piperidine.

13. The compound of claim 1 , wherein Y is bond, alkyl, aryl, or COO.

14. The compound of claim 1 , wherein Y is pyridine or piperidine.

15. The compound of claim 13 , wherein Y is COO.

16. The compound of claim 1 , wherein R 5 is —H, substituted and unsubstituted alkyl, substituted and unsubstituted heteroalkyl, and substituted and unsubstituted aryl.

17. The compound of claim 16 , wherein R 5 is aryl or substituted aryl.

18. The compound of claim 17 , wherein R 5 is phenyl or benzyl.

19. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 in a pharmaceutically-acceptable carrier.

20. A method for treating colon cancer in a mammal comprising administering to said mammal a therapeutically effective amount of a compound of claim 1 .

21. A compound, including pharmaceutically acceptable salts thereof, having the structure of:

3-Benzyloxy-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide,

3-Benzyloxy-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(4-dimethylamino-benzylamide) 4-hydroxyamide,

3-Benzyloxy-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(3-dimethylamino-2,2-dimethyl-propyl)-amide]4-hydroxyamide,

3-(4-Methoxy-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(4-dimethylaminobenzylamide)4-hydroxyamide,

3-(4-Methoxy-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(4-dimethylamino-benzylamide)4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-{[3-(2-methyl-piperidin-1-yl)-propyl]-amide},

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(3-dimethylamino-propyl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(3-dimethylamino-2,2-dimethyl-propyl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(3-piperidin-1-yl-propyl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(3-diethylamino-propyl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(3-dibutylamino-propyl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(4-amino-benzylamide)4-hydoxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(2-diethylamino-ethyl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-{[3-(4-methyl-piperazin-1-yl)-propyl]-amide},

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(4-aminomethyl-benzylamide)4-hydroxyamide,

6-{[3-(3,4-Dichloro-benzyloxy) 4 -hydroxycarbamoyl-1-methyl-1H-pyrrole-2-carbonyl]-amino}-hexanoic acid methyl ester,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(3,4-dihydroxy-benzylamide)4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy) 4 -hydroxycarbamoyl-1-methyl-1H-pyrrole-2-carboxylic acid 1-benzyl-piperidin-4-yl ester,

5-([1,4′]Bipiperidinyl-1′-carbonyl)-4-(3,4-dichloro-benzyloxy)-1-methyl-1H-pyrrole-3-carboxylic acid hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(1-naphthalen-1-yl-ethyl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(benzo[1,3]dioxol-5-ylmethyl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-{[(4-methyl-pyridin-2-yl)-phenyl-methyl]-amide},

5-(N′-Benzyl-hydrazinocarbonyl)-4-(3,4-dichloro-benzyloxy)-1-methyl-1H-pyrrole-3-carboxylic acid hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-{[2-(1-benzyl-piperidin-4-ylamino)-phenyl]-amide}4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-{[4-(4-methyl-piperidin-1-yl)-phenyl]-amide},

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-piperidin-4-ylamide,

5-(4-Amino-piperidine-1-carbonyl)-4-(3,4-dichloro-benzyloxy)-1-methyl-1H-pyrrole-3-carboxylic acid hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-{[1-(4-dimethylamino-butyryl)-piperidin-4-yl]-amide}4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-{[1-(4-cyano-benzyl)-piperidin-4-yl]-amide}4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 4-[(1,2,2,6,6-pentamethyl-piperidin-4-yl)-amide],

4-{[3-(3,4-Dichloro-benzyloxy) 4 -hydroxycarbamoyl-1-methyl-1H-pyrrole-2-carbonyl]-amino}-piperidine-1-carboxylic acid ethyl ester,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-indan-1-ylamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(9H-fluoren-9-yl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(1,2,3,4-tetrahydro-naphthalen-1-yl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4- hydroxyamide 2-piperidin-1-ylamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(2-hydroxy-indan-1-yl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-pyrrolidin-3-yl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(2-hydroxy-indan-1-yl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-[(2-carbamoyl-cyclohexyl)-amide]4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-benzylamide 4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-(2-methoxy-benzylamide),

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-(3-methoxy-benzylamide),

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(2,4-dimethoxy-benzylamide)4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(3,4-dimethoxy-benzylamide) 4 -hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 4-(2,4,6-trimethoxy-benzylamide),

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-{[2-(4-hydroxy-phenyl)-ethyl]-amide},

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(pyridin-3-ylmethyl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(pyridin-4-ylmethyl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-[(pyridin-2-ylmethyl)-amide],

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-(4-pentyl-benzylamide),

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-{[2-(2-chloro-6-fluoro-benzylsulfanyl)-ethyl]-amide}4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-{[2-(2,6-dichloro-benzylsulfanyl)-ethyl]-amide}4-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-{[3-(3-acetylamino-phenoxy)-propyl]-amide}4-hydroxyamide,

4-({[3-(3,4-Dichloro-benzyloxy)-4-hydroxycarbamoyl-1-methyl-1H-pyrrole-2-carbonyl]-amino}-methyl)-benzoic acid methyl ester,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-hydroxyamide 2-(4-methyl-benzylamide),

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-(2-chloro-6-phenoxy-benzylamide)4-hydroxyamide,

3-(2,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(4-dimethylamino-benzylamide)4-hydroxyamide,

3-(2,6-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 2-(4-dimethylamino-benzylamide)4-hydroxyamide,

1-Benzyl-3-(3,4-dichloro-benzyloxy)-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide,

1-Benzyl-3-(3,4-dichloro-benzyloxy)-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-3-yl)-amide]4-hydroxyamide,

1-Benzyl-3-(3,4-dichloro-benzyloxy)-1H-pyrrole-2,4-dicarboxylic acid 2-{[2-(1-benzyl-piperidin-4-ylamino)-phenyl]-amide}4-hydroxyamide,

3-Benzyloxy-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-4-yl)-amide]2-hydroxyamide,

3-(4-Methoxy-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-4-yl)-amide]2-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-(4-dimethylamino-benzylamide)2-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-4-yl)-amide]2-hydroxyamide,

3-(3,4-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-3-yl)-amide]2-hydroxyamide,

3-(2,6-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-4-yl)-amide]2-hydroxyamide,

3-(2,6-Dichloro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-3-yl)-amide]2-hydroxyamide,

3-(4-Cyano-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-3-yl)-amide]2-hydroxyamide,

3-(4-Cyano-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-4-yl)-amide]2-hydroxyamide,

1-Methyl-3-(pyridin-4-ylmethoxy)-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-4-yl)-amide]2-hydroxyamide,

1-Methyl-3-(pyridin-4-ylmethoxy)-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-3-yl)-amide]2-hydroxyamide, or,

3-(3,4-Difluoro-benzyloxy)-1-methyl-1H-pyrrole-2,4-dicarboxylic acid 4-[(1-benzyl-piperidin-4-yl)-amide]2-hydroxyamide.

22. The compound of claim 1 having the structure

Assignments (2)
SECURITY AGREEMENT Recorded Oct 28, 2008
From: AVALON PHARMACEUTICALS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 021744/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2003
From: CHOLODY, WIESLAW M.; PETUKHOVA, VALENTINA; O'BRIEN, SEAN; OHLER, NORMAN; PIKUL, STANISLAW
To: AVALON PHARMACEUTICALS, INC.
Reel/Frame 014670/0491 →